Daiwa Securities Group Inc. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,461 shares of the medical equipment provider’s stock after acquiring an additional 271 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Intuitive Surgical were worth $2,561,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Arrow Financial Corp purchased a new stake in Intuitive Surgical during the third quarter valued at $115,000. JNBA Financial Advisors purchased a new stake in Intuitive Surgical during the third quarter valued at $115,000. Optimum Investment Advisors increased its position in Intuitive Surgical by 189.9% during the third quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock valued at $131,000 after acquiring an additional 150 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Intuitive Surgical during the third quarter valued at $137,000. Finally, Adviser Investments LLC purchased a new stake in Intuitive Surgical during the second quarter valued at $115,000. Institutional investors own 84.16% of the company’s stock.
Shares of ISRG opened at $532.56 on Friday. The stock has a market capitalization of $59.35 billion, a price-to-earnings ratio of 74.07, a P/E/G ratio of 3.49 and a beta of 1.02. Intuitive Surgical, Inc. has a 52 week low of $359.75 and a 52 week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping analysts’ consensus estimates of $2.66 by $0.17. The business had revenue of $920.90 million during the quarter, compared to analysts’ expectations of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The business’s quarterly revenue was up 14.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.77 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 9.52 EPS for the current year.
In related news, Director Lonnie M. Smith sold 225 shares of the stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $540.04, for a total transaction of $121,509.00. Following the completion of the sale, the director now owns 379,175 shares in the company, valued at $204,769,667. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 1,000 shares of the stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $500.00, for a total value of $500,000.00. Following the sale, the director now owns 9,874 shares of the company’s stock, valued at approximately $4,937,000. The disclosure for this sale can be found here. Insiders have sold 47,311 shares of company stock valued at $24,144,846 in the last quarter. 2.20% of the stock is currently owned by company insiders.
A number of analysts recently commented on ISRG shares. Bank of America upped their price objective on Intuitive Surgical from $510.00 to $600.00 and gave the company a “buy” rating in a research report on Tuesday, July 17th. Cantor Fitzgerald reiterated a “buy” rating and set a $620.00 price objective (up previously from $510.00) on shares of Intuitive Surgical in a research report on Friday, July 20th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $575.00 price objective on shares of Intuitive Surgical in a research report on Friday, July 20th. Royal Bank of Canada set a $550.00 price objective on Intuitive Surgical and gave the company a “hold” rating in a research report on Friday, July 20th. Finally, Morgan Stanley restated an “overweight” rating and issued a $575.00 price target (up previously from $535.00) on shares of Intuitive Surgical in a research report on Friday, July 20th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have assigned a buy rating to the stock. Intuitive Surgical currently has a consensus rating of “Buy” and a consensus price target of $554.64.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Further Reading: How can investors find ex-dividend dates?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.